Please assess the completion status of the following clinical trial:

Trial Title: Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ability and acceptance to provide written consent, fluent in English;~* Healthy subjects with no medical, psychiatric or current sleep disorders;~* Men or women between 18-75 years;~* Body Mass Index of ≥ 18 and ≤ 30 kg/m2.~Exclusion Criteria:~* Major surgery, trauma, illness or immobile for 3 or more days within the past month;~* Pregnancy or recent pregnancy (within 6 weeks);~* A positive test for drugs of abuse at the screening or evaluation visit.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Tasimelteon (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).